Stay updated with breaking news from Tal Gilat. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- NeuroGenesis, a clinical-stage biopharmaceutical company advancing innovative cell therapies to combat myelin-related neurodegenerative...
By Yakir Benzion, United With Israel A phase two study at Jerusalem’s Hadassah Ein Kerem Hospital has revealed significant clinical improvements in patients with progressive multiple sclerosis (MS) after being treated with NG-01 stem cells developed by NeuroGenesis, a biopharmaceutical company associated with Hadassah that develops cell therapies to combat neurodegenerative diseases. The 14-month study tested how 48 patients responded to the treatment using NG-01 stem cells that are “autologous,” meaning that they are obtained from the patients themselves. The stem cells are obtained fr...